SCS-C005994

Diacarlactone A

Pathway: Terpenoids

Chemical Structure

Structure of Diacarlactone A
Loading 3D structure...
3D conformers are computationally generated from SMILES by RDKit for visualization and download; they are not experimental crystal or NMR structures.
Download: SDF SMILES

Source Information

Diacarnus megaspinorhabdosa (NA)
South China Sea
DOI: 10.1248/cpb.c15-00022  · CHEMICAL & PHARMACEUTICAL BULLETIN

Drug-likeness (Lipinski Ro5)

Molecular Weight
350.5 Da
Threshold ≤ 500
ALogP
4.94
Threshold ≤ 5
H-Bond Donors
0
Threshold ≤ 5
H-Bond Acceptors
4
Threshold ≤ 10
Passes Lipinski Rule of Five — drug-like candidate

Chemical Properties

Molecular Formula:
C21H34O4
Molecular Weight:
350.4990 Da
SMILES:
CC(=O)CCCC(C)(C)C(=O)CC/C(C)=C/CC[C@]1(C)CCC(=O)O1
InChIKey:
AABSRFLRNFXOQB-ZXSWEOGUSA-N
InChI:
InChI=1S/C21H34O4/c1-16(8-6-14-21(5)15-12-19(24)25-21)10-11-18(23)20(3,4)13-7-9-17(2)22/h8H,6-7,9-15H2,1-5H3/b16-8+/t21-/m1/s1
Calculated Properties
ALogP:
4.943 lipophilicity
TPSA:
60.44 Ų polar surface area
H-Bond Donors:
0
H-Bond Acceptors:
4
Rotatable Bonds:
11
Ring Count:
1 (0 aromatic)
Chiral Centers:
1
Fsp³:
0.7619 fraction sp³ carbon

Database Information

Compound ID:
SCS-C005994
NPClassifier Pathway:
Terpenoids
NPClassifier Superclass:
N/A
NPClassifier Class:
N/A
Glycoside:
No
NPClassifier Status:
Classified
External Links:

Biological Activity Data

Activity values are displayed only when a quantitative or clearly reported result is available. Tested organisms, cell lines and molecular targets are shown under Target / model.
Activity Assay Target / model Result Reference
Antitumor IC50 NCI-H446 small-cell lung cancer cell line 18.5 μM 10.1248/cpb.c15-00022 CHEMICAL & PHARMACEUTICAL BULLETIN
Antitumor IC50 NCI-H460 large-cell lung cancer cell line 20.1 μM 10.1248/cpb.c15-00022 CHEMICAL & PHARMACEUTICAL BULLETIN
Antitumor IC50 SGC-7901 gastric carcinoma cell line 22.3 μM 10.1248/cpb.c15-00022 CHEMICAL & PHARMACEUTICAL BULLETIN
Antitumor IC50 HeLa cervical cancer cell line 26.7 μM 10.1248/cpb.c15-00022 CHEMICAL & PHARMACEUTICAL BULLETIN
Antitumor IC50 MCF-7 breast carcinoma cell line 47.1 μM 10.1248/cpb.c15-00022 CHEMICAL & PHARMACEUTICAL BULLETIN
Structure enlarged